---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286446293.md"
description: "Keros Therapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results."
datetime: "2026-05-14T16:36:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286446293.md)
  - [en](https://longbridge.com/en/news/286446293.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286446293.md)
generator: "portal-rs"
---

# 

Keros Therapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results.

### Related Stocks

- [KROS.US](https://longbridge.com/en/quote/KROS.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Lorena Raquel Lerner Sells 3,568 Shares of Keros Therapeutics (NASDAQ:KROS) Stock](https://longbridge.com/en/news/296537934.md)
- [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md)
- [Keros Therapeutics director Charles W. Newton sells 551 common shares worth $5,675.3](https://longbridge.com/en/news/296531453.md)
- [EverGen Infrastructure Reports Q2 2026 Results | EVGIF Stock News](https://longbridge.com/en/news/297122882.md)
- [Keros Therapeutics director Jean Jacques Bieneaime acquires USD 10,270 in common shares](https://longbridge.com/en/news/296395349.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**